TPSF
CYTK icon

Texas Permanent School Fund’s Cytokinetics CYTK Stock Holding History

Texas Permanent School Fund’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,816
Closed -$6.02M – 366
2024
Q1 		$6.02M Buy
85,816
+1,111
+1% +$85.9K 0.05% 452
2023
Q4 		$7.07M Buy
84,705
+4,262
+5% +$154K 0.06% 325
2023
Q3 		$2.37M Sell
80,443
-1,716
-2% -$57.1K 0.02% 866
2023
Q2 		$2.68M Sell
82,159
-3,843
-4% -$142K 0.02% 825
2023
Q1 		$3.03M Buy
86,002
+21,246
+33% +$867K 0.03% 736
2022
Q4 		$2.97M Sell
64,756
-2,953
-4% -$127K 0.05% 540
2022
Q3 		$3.28M Buy
67,709
+5,802
+9% +$279K 0.05% 449
2022
Q2 		$2.43M Buy
61,907
+2,438
+4% +$98.2K 0.04% 645
2022
Q1 		$2.19M Sell
59,469
-1,008
-2% -$35.8K 0.03% 800
2021
Q4 		$2.76M Sell
60,477
-1,300
-2% -$50.2K 0.03% 709
2021
Q3 		$2.21M Buy
61,777
+8,316
+16% +$245K 0.03% 838
2021
Q2 		$1.06M Buy
53,461
+334
+0.6% +$7.84K 0.01% 1208
2021
Q1 		$1.24M Sell
53,127
-3,705
-7% -$79.1K 0.02% 1140
2020
Q4 		$1.18M Sell
56,832
-9,030
-14% -$165K 0.01% 1099
2020
Q3 		$1.43M Buy
65,862
+18,876
+40% +$442K 0.02% 961
2020
Q2 		$1.11M Sell
46,986
-3,300
-7% -$61.9K 0.02% 989
2020
Q1 		$593K Buy
50,286
+9,873
+24% +$126K 0.01% 1173
2019
Q4 		$429K Buy
40,413
+474
+1% +$4.87K 0.01% 1363
2019
Q3 		$455K Buy
39,939
+765
+2% +$9.6K 0.01% 1338
2019
Q2 		$441K Buy
39,174
+2,026
+5% +$19.5K 0.01% 1343
2019
Q1 		$301K Buy
37,148
+1,346
+4% +$9.9K ﹤0.01% 1430
2018
Q4 		$226K Buy
35,802
+1,430
+4% +$10.5K ﹤0.01% 1456
2018
Q3 		$339K Buy
34,372
+1,492
+5% +$12K ﹤0.01% 1428
2018
Q2 		$273K Sell
32,880
-653
-2% -$5.43K ﹤0.01% 1472
2018
Q1 		$241K Sell
33,533
-706
-2% -$6.05K ﹤0.01% 1472
2017
Q4 		$279K Sell
34,239
-2,590
-7% -$29.4K ﹤0.01% 1456
2017
Q3 		$534K Buy
36,829
+3,067
+9% +$41.9K 0.01% 1344
2017
Q2 		$409K Buy
+33,762
New +$469K 0.01% 1388

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Texas Permanent School Fund's CYTK Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 85,816 shares — an estimated $6.02M sold.

Texas Permanent School Fund first reported a position in CYTK in Q2 2017 and held it in 28 quarters. The position peaked at $7.07M in Q4 2023. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 85,816 Cytokinetics shares in Q2 2024, an estimated $6.02M.
  • Texas Permanent School Fund first reported a position in Cytokinetics in Q2 2017 and held it in 28 quarters.
  • Texas Permanent School Fund's Cytokinetics position peaked at $7.07M in Q4 2023.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.